MedEye Minute Newsletter

Connect

Fluorescence Lifetime Imaging Ophthalmoscopy

Do you know FLIO?... Fluorescence lifetime imaging ophthalmoscopy, aka FLIO, is positioned to revolutionize neuro-ophthalmology and neurology by providing unprecedented insights into metabolic processes of the retina. The technology behind FLIO has demonstrated advanced potential in diagnosing ...

by John R Martinelli MD OD FAAO — Mar 25, 2025

TIME.

Are your patients teaching you to be the best you can be? When we work with patients, real people, a tactful 5 minute investment in conversation can yield an exponential return on many levels. We can often have a top differential in our head in even less time, sometimes seconds, before actually...

by John R Martinelli MD OD FAAO — Mar 22, 2025

Corneal Microneedle Treatment

Does it hurt?... An annular corneal microneedle patch will likely become a significant advancement in minimally invasive ophthalmic drug delivery, designed specifically to address the challenges faced with traditional topical eye drops. This innovative solution offers several key advantages, ma...

by John R Martinelli MD OD FAAO — Mar 20, 2025

BLIND is a 4 Letter Word.

Why do you use it?... I'm not a fan of the word blind. In fact, in my 37 years of private practice, I have not once uttered the words blind, going blind, blindness, risk of going blind, etc. to any patient. I have never found the need to. I have too much respect for it. I'm speaking from a very...

by John R Martinelli MD OD FAAO — Mar 16, 2025

Topical Anti-VEGF On The Horizon

Do you know the latest?... Can sustained suppression of VEGF be accomplished through topical ocular medications? This question represents an exciting future, particularly for treating retinal vascular diseases like neovascular age-related macular degeneration and diabetic macular edema. While in...

by John R Martinelli MD OD FAAO — Mar 13, 2025

A Port For Diabetic Macular Edema

Do you know it's happening now?... Continuous ranibizumab delivery via a Port Delivery System (PDS) with refill exchanges every 24 weeks has been found to provide non-inferior outcomes compared to monthly intravitreal injections for individuals with diabetic macular edema (DME). A phase 3 multic...

by John R Martinelli MD OD FAAO — Mar 11, 2025

How To Practice PRIMARY CARE.

Thoughts on taking care of people... Let's get right to it... Taking care of people and primary care should not be a gateway to the referral merry-go-round wasting resources, precious time, expense, and most unfortunate leading to the creation of greater patient anxiety due to lack of prompt solu...

by John R Martinelli MD OD FAAO — Mar 09, 2025

NOT What You Think.

What will you tell your patient?... Benign yellow dot maculopathy (BYDM) is a recently recognized retinal condition characterized by distinctive yellow dots in the macular area. There is also a wide phenotypic spectrum - potentially extending beyond the vascular arcades. Recent understanding of i...

by John R Martinelli MD OD FAAO — Mar 06, 2025

Pterygium & Epigenetics

Do you know your histones?... Histones are structural components of chromatin, consider them the protein "glue" which holds our DNA together. It has been known they also regulate gene expression through epigenetic modifications. These modifications can be dynamic and reversible, allowing cells to...

by John R Martinelli MD OD FAAO — Mar 04, 2025

ERM: Hyperreflective Foci & OCTA

Are you looking for it?... Elevated hyperreflective foci are a newfound characteristic of idiopathic epiretinal membrane (iERM) we should be aware of. These foci were recently identified via optical coherence tomography angiography (OCTA) while studying changes in the retinal vitreous interface a...

by John R Martinelli MD OD FAAO — Feb 27, 2025

The Pituitary Neuro-Ophthalmic Approach

How well do you know it?... In ophthalmic medicine, our proper understanding of the "how & why" of neuro-ophthalmic concepts is key in diagnosis, prognosis, and management of pituitary conditions, particularly in scenarios involving potential compressive mass effects. Optical coherence tomograph...

by John R Martinelli MD OD FAAO — Feb 25, 2025

Cataract Surgery & Diabetic Retinopathy Progression

What do you tell your patients?... The risk of progression of non-proliferative diabetic retinopathy (NPDR) to proliferative diabetic retinopathy (PDR) following cataract surgery is always on our minds in terms of outcomes for our patients. While modern phacoemulsification has reduced surgical tr...

by John R Martinelli MD OD FAAO — Feb 20, 2025

1 2 3 4 5 6 7 8

MedEye Minute Newsletter

Brief clinical reviews of things that matter.